Brief: Bioinvent to launch SEK 139 mln repair rights issue

BioInvent International AB

09/07/2020 16:33

July 9 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT'S BOARD OF DIRECTORS RESOLVE ON A REPAIR RIGHTS
ISSUE
OF A MAXIMUM OF APPROX. SEK 139 MILLION, FOLLOWING THE
SUCCESSFULLY COMPLETED DIRECTED SHARE ISSUE OF APPROX. SEK
487 MILLION
    * BIOINVENT SAYS SUBSCRIPTION PRICE IN RIGHTS ISSUE WILL BE
SEK
1.38 PER SHARE, WHICH IS SAME AS PRICE PER SHARE PAID IN
DIRECTED SHARE ISSUE
    * BIOINVENT SAYS PROVIDED THAT RIGHTS ISSUE IS FULLY
SUBSCRIBED A
MAXIMUM NUMBER OF 100,527,062 SHARES WILL BE ISSUED AND COMPANY
WILL RECEIVE APPROXIMATELY SEK 139 MILLION BEFORE TRANSACTION
COSTS.
    * BIOINVENT SAYS NET PROCEEDS FROM RIGHTS ISSUE ARE MAINLY
INTENDED FOR PROGRESSING AND EXPANDING CLINICAL DEVELOPMENT OF
BI-1206,

Source text for Eikon:  ID:nWkr2mDr42 
Further company coverage:  BINV.ST 

 (Reporting By Johan Ahlander)
 ((johan.ahlander@thomsonreuters.com;))